AngioDynamics to Participate in Upcoming Investor Conferences
LATHAM, N.Y.–(BUSINESS WIRE)–
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that its management team is scheduled to participate in the following upcoming investor conferences:
11th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference
Monday, August 10, 2026
Canaccord Genuity’s 46th Annual Growth Conference
Presentation: Tuesday, August 11, 2026 from 3:30-3:55 PM ET
A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com.
About AngioDynamics, Inc.
AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients.
The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260728796556/en/
Investors:
Stephen Trowbridge
Executive Vice President & CFO
518-795-1408
[email protected]
Media:
Saleem Cheeks
Vice President, Communications
518-795-1174
[email protected]
KEYWORDS: New York United States North America
INDUSTRY KEYWORDS: Oncology Medical Devices Health Health Technology Cardiology Biotechnology
MEDIA: